MZP · Class II · 21 CFR 866.3170

FDA Product Code MZP: Assay, Hybridization And/or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,hepatitis C Virus

FDA product code MZP covers hybridization and nucleic acid amplification assays used for pathogen identification from clinical specimens.

These molecular tests use probe hybridization or amplification techniques to detect specific nucleic acid sequences from bacteria, fungi, viruses, or parasites, providing pathogen identification from culture isolates or directly from clinical specimens.

MZP devices are Class II medical devices, regulated under 21 CFR 866.3170 and reviewed by the FDA Microbiology panel.

Leading manufacturers include Roche Molecular Systems, Inc. and Hologic, Inc..

3
Total
3
Cleared
200d
Avg days
2022
Since

List of Assay, Hybridization And/or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,hepatitis C Virus devices cleared through 510(k)

3 devices
1–3 of 3

How to use this database

This page lists all FDA 510(k) submissions for Assay, Hybridization And/or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,hepatitis C Virus devices (product code MZP). Click any device to view full submission details, including the decision date, manufacturer information, predicate device, and a link to the official FDA record.

These devices fall under the Microbiology FDA review panel. Browse all Microbiology devices →